Loading...

Intracellular Staining Permeabilization Wash Buffer (10X) Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  2. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  3. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  4. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  5. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  6. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  7. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  8. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  9. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  10. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  11. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  12. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  13. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  14. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  15. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  16. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  17. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  18. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  19. Chan L, et al. 2022. Cells. 12: . PubMed
  20. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  21. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  22. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  23. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  24. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  25. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  26. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  27. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  28. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  29. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  30. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  31. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  32. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  33. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  34. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  35. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  36. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  37. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  38. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  39. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  40. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  41. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  42. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  43. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  44. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  45. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  46. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  47. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  48. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  49. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  50. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  51. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  52. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  53. Kim S, et al. 2020. Development. 147:00:00. PubMed
  54. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  55. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  56. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  57. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  58. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  59. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  60. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  61. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  62. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  63. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  64. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  65. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  66. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  67. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  68. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  69. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  70. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  71. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  72. Poli V, et al. 2021. iScience. 24:103256. PubMed
  73. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  74. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  75. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  76. Stewart CA, et al. 2020. bioRxiv. . PubMed
  77. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  78. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  79. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  80. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  81. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  82. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  83. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  84. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  85. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  86. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  87. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  88. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  89. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  90. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  91. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  92. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  93. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  94. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  95. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  96. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  97. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  98. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  99. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  100. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  101. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  102. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  103. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  104. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  105. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  106. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  107. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  108. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  109. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  110. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  111. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  112. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  113. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  114. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  115. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  116. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  117. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  118. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  119. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  120. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  121. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  122. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  123. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  124. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  125. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  126. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  127. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  128. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  129. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  130. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  131. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  132. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  133. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  134. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  135. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  136. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  139. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  140. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  141. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  142. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  143. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  144. Kim S, et al. 2020. Development. . PubMed
  145. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  146. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  147. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  148. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  149. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  150. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  151. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  152. Ma K, et al. 2022. iScience. 25:104347. PubMed
  153. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  154. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  155. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  156. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  157. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  158. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  159. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  160. Lau H, et al. 2020. Islets. 41:12. PubMed
  161. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  162. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  163. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  164. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  165. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  166. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  167. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  168. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  169. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  170. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  171. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  172. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  173. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  174. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  175. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  176. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  177. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  178. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  179. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  180. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  181. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  182. Lee G, et al. 2021. Viruses. 13: . PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  186. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  191. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  192. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  193. Wang X, et al. 2022. Elife. 11:. PubMed
  194. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  195. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  196. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  197. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  198. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  199. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  205. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  206. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  207. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  208. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  209. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  210. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  211. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  212. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  213. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  214. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  215. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  216. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  217. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  218. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  219. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  220. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  221. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  222. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  223. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  224. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  225. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  226. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  227. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  228. Chan L, et al. 2022. Cells. 12: . PubMed
  229. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  230. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  231. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  232. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  233. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  234. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  235. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  236. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  237. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  238. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  239. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  240. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  241. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  242. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  243. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  244. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  245. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  246. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  247. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  248. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  249. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  250. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  251. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  252. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  253. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  254. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  255. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  256. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  257. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  258. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  259. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  260. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  261. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  262. Kim S, et al. 2020. Development. 147:00:00. PubMed
  263. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  264. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  265. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  266. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  267. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  268. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  269. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  270. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  271. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  272. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  273. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  274. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  275. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  276. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  277. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  278. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  279. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  280. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  281. Poli V, et al. 2021. iScience. 24:103256. PubMed
  282. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  283. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  284. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  285. Stewart CA, et al. 2020. bioRxiv. . PubMed
  286. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  287. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  288. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  289. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  290. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  291. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  292. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  293. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  294. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  295. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  296. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  297. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  298. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  299. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  300. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  301. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  302. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  303. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  304. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  305. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  306. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  307. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  308. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  309. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  310. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  311. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  312. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  313. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  314. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  315. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  316. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  317. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  318. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  319. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  320. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  321. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  322. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  323. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  324. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  325. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  326. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  327. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  328. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  329. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  330. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  331. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  332. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  333. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  334. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  335. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  336. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  337. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  338. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  339. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  340. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  341. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  342. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  343. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  344. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  345. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  346. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  347. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  348. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  349. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  350. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  351. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  352. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  353. Kim S, et al. 2020. Development. . PubMed
  354. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  355. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  356. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  357. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  358. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  359. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  360. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  361. Ma K, et al. 2022. iScience. 25:104347. PubMed
  362. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  363. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  364. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  365. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  366. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  367. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  368. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  369. Lau H, et al. 2020. Islets. 41:12. PubMed
  370. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  371. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  372. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  373. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  374. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  375. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  376. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  377. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  378. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  379. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  380. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  381. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  382. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  383. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  384. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  385. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  386. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  387. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  388. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  389. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  390. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  391. Lee G, et al. 2021. Viruses. 13: . PubMed
  392. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  393. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  394. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  395. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  396. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  397. Su Y, et al. 2020. Cell. 1479:183. PubMed
  398. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  399. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  400. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  401. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  402. Wang X, et al. 2022. Elife. 11:. PubMed
  403. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  404. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  405. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  406. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  407. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  408. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  414. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  415. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  416. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  417. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  418. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08.26.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  2. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  3. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  4. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  5. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  6. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  7. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  8. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  9. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  10. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  11. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  12. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  13. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  14. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  15. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  16. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  17. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  18. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  19. Chan L, et al. 2022. Cells. 12: . PubMed
  20. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  21. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  22. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  23. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  24. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  25. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  26. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  27. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  28. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  29. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  30. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  31. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  32. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  33. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  34. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  35. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  36. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  37. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  38. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  39. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  40. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  41. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  42. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  43. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  44. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  45. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  46. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  47. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  48. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  49. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  50. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  51. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  52. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  53. Kim S, et al. 2020. Development. 147:00:00. PubMed
  54. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  55. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  56. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  57. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  58. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  59. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  60. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  61. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  62. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  63. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  64. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  65. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  66. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  67. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  68. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  69. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  70. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  71. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  72. Poli V, et al. 2021. iScience. 24:103256. PubMed
  73. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  74. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  75. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  76. Stewart CA, et al. 2020. bioRxiv. . PubMed
  77. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  78. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  79. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  80. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  81. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  82. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  83. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  84. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  85. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  86. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  87. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  88. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  89. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  90. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  91. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  92. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  93. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  94. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  95. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  96. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  97. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  98. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  99. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  100. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  101. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  102. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  103. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  104. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  105. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  106. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  107. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  108. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  109. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  110. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  111. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  112. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  113. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  114. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  115. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  116. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  117. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  118. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  119. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  120. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  121. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  122. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  123. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  124. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  125. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  126. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  127. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  128. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  129. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  130. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  131. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  132. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  133. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  134. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  135. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  136. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  139. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  140. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  141. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  142. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  143. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  144. Kim S, et al. 2020. Development. . PubMed
  145. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  146. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  147. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  148. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  149. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  150. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  151. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  152. Ma K, et al. 2022. iScience. 25:104347. PubMed
  153. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  154. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  155. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  156. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  157. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  158. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  159. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  160. Lau H, et al. 2020. Islets. 41:12. PubMed
  161. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  162. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  163. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  164. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  165. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  166. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  167. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  168. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  169. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  170. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  171. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  172. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  173. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  174. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  175. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  176. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  177. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  178. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  179. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  180. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  181. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  182. Lee G, et al. 2021. Viruses. 13: . PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  186. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  191. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  192. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  193. Wang X, et al. 2022. Elife. 11:. PubMed
  194. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  195. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  196. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  197. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  198. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  199. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  205. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  206. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  207. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  208. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  209. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  210. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  211. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  212. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  213. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  214. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  215. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  216. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  217. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  218. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  219. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  220. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  221. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  222. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  223. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  224. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  225. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  226. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  227. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  228. Chan L, et al. 2022. Cells. 12: . PubMed
  229. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  230. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  231. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  232. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  233. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  234. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  235. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  236. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  237. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  238. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  239. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  240. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  241. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  242. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  243. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  244. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  245. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  246. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  247. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  248. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  249. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  250. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  251. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  252. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  253. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  254. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  255. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  256. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  257. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  258. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  259. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  260. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  261. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  262. Kim S, et al. 2020. Development. 147:00:00. PubMed
  263. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  264. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  265. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  266. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  267. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  268. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  269. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  270. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  271. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  272. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  273. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  274. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  275. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  276. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  277. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  278. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  279. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  280. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  281. Poli V, et al. 2021. iScience. 24:103256. PubMed
  282. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  283. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  284. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  285. Stewart CA, et al. 2020. bioRxiv. . PubMed
  286. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  287. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  288. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  289. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  290. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  291. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  292. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  293. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  294. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  295. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  296. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  297. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  298. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  299. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  300. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  301. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  302. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  303. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  304. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  305. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  306. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  307. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  308. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  309. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  310. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  311. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  312. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  313. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  314. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  315. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  316. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  317. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  318. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  319. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  320. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  321. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  322. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  323. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  324. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  325. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  326. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  327. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  328. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  329. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  330. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  331. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  332. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  333. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  334. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  335. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  336. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  337. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  338. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  339. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  340. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  341. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  342. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  343. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  344. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  345. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  346. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  347. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  348. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  349. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  350. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  351. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  352. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  353. Kim S, et al. 2020. Development. . PubMed
  354. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  355. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  356. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  357. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  358. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  359. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  360. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  361. Ma K, et al. 2022. iScience. 25:104347. PubMed
  362. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  363. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  364. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  365. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  366. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  367. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  368. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  369. Lau H, et al. 2020. Islets. 41:12. PubMed
  370. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  371. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  372. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  373. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  374. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  375. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  376. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  377. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  378. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  379. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  380. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  381. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  382. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  383. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  384. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  385. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  386. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  387. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  388. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  389. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  390. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  391. Lee G, et al. 2021. Viruses. 13: . PubMed
  392. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  393. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  394. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  395. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  396. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  397. Su Y, et al. 2020. Cell. 1479:183. PubMed
  398. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  399. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  400. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  401. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  402. Wang X, et al. 2022. Elife. 11:. PubMed
  403. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  404. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  405. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  406. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  407. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  408. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  414. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  415. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  416. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  417. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  418. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 3    Revision Date: 08.26.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account